Search results
Update on the Sesen Bio, Inc. (SESN) investors lawsuit. On June 3, 2022, the lead plaintiffs and the defendants told the court they would enter into a mediation session on June 30, 2022.
- Hot
Get app Get the Reddit app Log In Log in to Reddit. Expand...
- Sesn Sells Ebi-031 to Roche for up to 70 Million
On July 18, 2022, Sesen Bio, Inc. (the “Company”) announced...
- Comments
1.5K subscribers in the SESN community. A community to...
- Sesn/Carisma
Anyone know what happens to our shares with this "reverse"...
- Class Action Update
I'm holding a few shares in my JP Morgan investing account,...
- ProxyVote
r/SESN A chip A close button. Get app Get the Reddit app Log...
- Still Holding This Bag
Posted by u/Oudeur - 5 votes and 5 comments
- Hot
Why Sesen Bio Stock Is Soaring Today Keith Speights | Feb 16, 2021 The FDA accepted the company's filing for approval of Vicineum in treating bladder cancer.
Find the latest Sesen Bio Inc (SESN) discussion and analysis from iHub's community of investors.
Sesen Bio stock quote and SESN charts. Latest stock price today and the US' most active stock market forums.
Live educational sessions using site features to explore today's markets. Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today announced that its stockholders have voted to approve all proposals, including the pending merger with Carisma Therapeutics...
13 sie 2021 · Sesen Bio Inc. (NASDAQ:SESN) shares traded higher Friday on anticipation of the announcement of the company's expected FDA decision. The decision was made that the company’s Biologics License...
16 sie 2021 · Sesen Bio Inc (NASDAQ: SESN) is trading significantly lower Monday after the U.S. Food and Drug Administration issued a Complete Response Letter for the company's bladder cancer candidate...
